Intravenous Infusions is trading 9.7% up at GHS 0.79 today, extending a week-long rally that appears driven by market sentiment rather than specific corporate developments.
- The share price has climbed significantly from GHS 0.46 on July 20 to its current level of GHS 0.79 as of July 28.
- Public news and regulatory filings show no fresh, company-specific announcements tied to the recent price action.
- The move suggests the gains are linked to broader strength in the healthcare sector and positive investor momentum.